The Canadian recreational cannabis market is one of the most exciting markets in the world. We look at how companies are positioning themselves, and identify one small recreational brand to have a look at.
Opinion
Biotech M&A Momentum Attractive for Cannabinoid R&D Space
With growing interest in the convergence of cannabis and medicine, companies like InMed Pharmaceuticals may find themselves on the radar of Big Pharma.
Cannabis Biotechs Could be Big Pharma’s Latest M&A Focus
InMed’s promising biosynthesis platform could put it on the radar of some major names seeking entry into one the pharmaceutical industry’s fastest-growing sectors.
The Absolute Number One Reason To Buy Marijuana Stocks Today
Forget everything you’ve heard up to now about marijuana stocks, a recent survey reveals the best reason to invest in marijuana today.
Who were Largest Marijuana Companies in 2016?
It’s not just thatPot Stocks are hot, but add Cannabis Biotech's to the fire and you get explosive wealth making opportunities… Of the 10 largest MJ Stocks (by market cap) nine are biotech/pharma firms and just one “touches the plant.”
FDA approves large-scale clinical trials of ecstasy to treat patients with PTSD
US scientists will treat 230 patients with the rave drug ecstasy aka MDMA MDMA is classed Class A (Schedule 1 in the US) alongside heroin and LSD It is known for giving clubbers a psychotic feeling of happiness But researchers claim it could help ease symptoms of autism or PTSD The FDA has approved large-scale clinical trials of ecstasy to treat patients with post-traumatic stress disorder.